Microbix Biosystems (TSE:MBX) Stock Passes Below 50 Day Moving Average – Time to Sell?

Microbix Biosystems Inc. (TSE:MBX) passed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of C$0.24 and traded as low as C$0.23. Microbix Biosystems shares last traded at C$0.23, with a volume of 242,440 shares traded.

Microbix Biosystems Stock Performance

The stock has a 50 day moving average of C$0.24 and a 200-day moving average of C$0.25. The company has a market capitalization of C$30.54 million, a P/E ratio of -13.75 and a beta of 0.03. The company has a current ratio of 7.15, a quick ratio of 5.57 and a debt-to-equity ratio of 22.61.

Microbix Biosystems (TSE:MBX) last released its earnings results on Thursday, December 18th. The company reported C($0.01) EPS for the quarter. Microbix Biosystems had a return on equity of 12.65% and a net margin of 13.86%.The firm had revenue of C$3.74 million for the quarter. On average, research analysts predict that Microbix Biosystems Inc. will post 0.02 EPS for the current year.

About Microbix Biosystems

Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows.